Botanical species · safety record

Coix lacryma-jobi

The EFSA Compendium of Botanicals holds 1 adverse-effect record for Coix lacryma-jobi. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Coix lacryma-jobi L.

0Constituent measurements
1Safety records
1Cited sources
46Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 46 licensed products naming Coix lacryma-jobi as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Coix lacryma-jobi - seed
  • Fruit extract
  • Kernel
  • Ripe Kernel
  • Seed (Stir-baked)
  • Seed (fried)
  • Seed extract
  • Seed(s)

What the records describe

Plant parts

  • Seed1

Preparations

  • Solvent extraction1

Effect types

  • Reproductive1

Target tissues

  • Uterus1

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUterusSeedSolvent extractionRat (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Tzeng, H.-P., Chiang, W., Ueng, T.-H., Liu, S.-H. The abortifacient effects from the seeds of Coix lachryma-jobi L. var. ma-yuen Stapf. Journal of Toxicology and Environmental Health - Part A, 2005, vol. 68, no. 17-18, p. 1557-1565. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue